Zepp Health says Q1 2026 revenue rose 33.8% to $51.5 million

Zepp Health (NYSE: ZEPP ) reported second-quarter financial results on Tuesday.

The transcript from the company's second-quarter earnings call has been provided below.

APIs provide real-time access to earnings call transcripts and financial data.

Visit to learn more.

Access the full call at Summary Zepp Health Corporation reported a 33.8% year-over-year increase in Q1 2026 revenue to $51.5 million, driven by new product launches such as the Amazfit Active Max and T-Rex Ultra 2.

The company is focusing on premiumization, evidenced by a 20% increase in average selling prices and the success of higher-priced models like the T-Rex Ultra 2.

Strategic initiatives include a new three-year partnership with HYROX to enhance their hybrid training platform and expand their reach in the endurance sports market.

Gross margin increased to 37.7%, despite higher memory costs and currency fluctuations, highlighting effective cost management and product mix improvements.

For Q2 2026, Zepp Health forecasts revenue between $63 million and $68 million, emphasizing quality growth and maintaining a path toward long-term profitability.

Full Transcript OPERATOR Hello, ladies and gentlemen.

Thank you for standing by for Zepp Health Corporation's first quarter 2026 earnings conference call.

At this time, all participants are in listen-only mode.

Today's conference call is being recorded.

I will now turn the call over to your host, Ms.

Grace Zhong, Director of Investor Relations for the company.

Please go ahead, Grace.

Grace Zhong, Director of Investor Relations Hello everyone, and welcome to Zepp Health Corporation's first quarter 2026 earnings conference call.

The company's financial and operating results were issued in a press release via the newswire services earlier today and are posted online.

You can also view the earnings press release and the slides referred to on this call by visiting the IR section of the company's website.

Presenting today are Wang Huang, our Founder and Chief Executive Officer, and Leon Deng, our Chief Financial Officer.

Joining us today we also have Mike Yang, Chief Operating Officer and General Manager of North America, and Eric Fleming, Vice President of Capital Markets for North America.

Before we continue, please note that today's discussion will contain forward-looking statements made under the safe harbor provisions of the U.S.

Private Securities Litigation Reform Act of 1995, forward-looking statements involving inherent risks and uncertainties.

As such, the company's actual results may be materially different from the views expressed today.

Further information regarding this and other risks and uncertainties are included in the company's Annual Report on Form 20-F for the fiscal year ended December 31, 2025 and other filings as filed with the U.S.

Securities and Exchange Commission.

The company does not assume any obligation to update any forward-looking statement except as required under applicable law.

Please also note that Zepp Health's earnings press release and this conference call include discussions of unaudited GAAP financial information as well as unaudited non-GAAP financial information.

Zepp Health's press release contains a reconciliation of unaudited non-GAAP measures to the unaudited, most directly comparable GAAP measures.

I will now turn the call over to our CEO, Mr.

Wang Huang.

Please go ahead.

Wang Huang, Chairman and CEO Hello everyone and thank you for joining us today.

We are pleased to begin 2026 with a promising start, delivering another solid quarter.

In the first quarter, Amazfit branded revenue grew 33.8% year over year, demonstrating exceptional resilience during what is traditionally a softer season for the consumer electronics industry.

This strong performance was primarily driven by the successful launches of the Amazfit Active Max, Active 3 Premium and our flagship T-Rex Ultra 2.